MARKET

IDYA

IDYA

Ideaya Biosciences
NASDAQ
30.81
+0.54
+1.77%
Opening 11:18 02/17 EST
OPEN
29.94
PREV CLOSE
30.27
HIGH
31.00
LOW
29.47
VOLUME
133.94K
TURNOVER
--
52 WEEK HIGH
39.28
52 WEEK LOW
13.45
MARKET CAP
2.70B
P/E (TTM)
-16.6101
1D
5D
1M
3M
1Y
5Y
1D
IDEAYA Biosciences GAAP EPS of -$0.94 beats by $0.03, revenue of $10.88M beats by $4.93M
Seeking Alpha · 6h ago
Earnings Scheduled For February 17, 2026
Benzinga · 6h ago
Ideaya Biosciences reports Q4 EPS (94c), consensus (95c)
TipRanks · 6h ago
IDEAYA Biosciences Q4 Earnings Report: What Investors Need to Know
Benzinga · 6h ago
IDEAYA Q4 profit slightly beats estimates
Reuters · 6h ago
IDEAYA Biosciences Q4 Loss Declines
NASDAQ · 6h ago
IDEAYA Biosciences Q4 collaboration revenue up 55.4% to USD 10.88 million
Reuters · 6h ago
IDEAYA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
Reuters · 6h ago
More
About IDYA
IDEAYA Biosciences, Inc. is a precision medicine oncology company. The Company is engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its lead product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 / GSK959 (Werner Helicase), IDE161 (PARG), and IDE705 / GSK101 (Pol Theta Helicase). IDE196, a small-molecule protein kinase C (PKC) inhibitor, in combination with crizotinib, an investigational cMET inhibitor. IDE397 is its small-molecule methionine adenosyltransferase 2a (MAT2A) inhibitor. IDE275 (GSK959) Werner Helicase (WRN) inhibitor for patients having tumors with MSI-High. IDE161 (PARG) is a small-molecule poly (ADP-ribose) glycohydrolase, or PARG, inhibitor. IDE705 is a small-molecule inhibitor of Pol Theta Helicase, in combination with niraparib, the GSK small-molecule inhibitor of poly-(ADP-ribose) polymerase (PARP).

Webull offers Ideaya Biosciences Inc stock information, including NASDAQ: IDYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IDYA stock methods without spending real money on the virtual paper trading platform.